Please Wait

Applying Filters...

Annual Sales of Eluxadoline reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Eluxadoline

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

10 API Suppliers, 5 USDMF, 4 NDC API, 7 Listed Suppliers, $ API Reference Price

INTERMEDIATES

6 API Suppliers

6 API Suppliers

FINISHED DOSAGE FORMULATIONS

8 FDF Dossiers, 6 FDA Orange Book, 2 Canada

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 2 Seqens, 3 DKSH, 6 Gangwal Healthcare, 1 Pfanstiehl, 3 Actylis, 1 Aeon Procare, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 10 BASF, 5 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 3 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 8 Kerry, 9 Microlex e.U, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 12 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

37 Fillers, Diluents & Binders, 21 Direct Compression, 20 Coating Systems & Additives, 16 Thickeners and Stabilizers, 13 Controlled & Modified Release, 13 Lubricants & Glidants, 11 Taste Masking, 11 Chewable & Orodispersible Aids, 11 Co-Processed Excipients, 9 Granulation, 8 Topical, 7 Parenteral, 6 Disintegrants & Superdisintegrants, 4 Film Formers & Plasticizers, 4 Solubilizers, 3 API Stability Enhancers, 3 Emulsifying Agents, 2 Coloring Agents, 1 Rheology Modifiers

DIGITAL CONTENT

2 DATA COMPILATION #PharmaFlow, 22 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 4 Annual Reports

MARKET PLACE

3 APIs

3 APIs

PATENTS & EXCLUSIVITIES

41 US Patents

41 US Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ Xls

Filters

Filters

FILTER :

filter Product Reset all filters

4 All

01 4Viberzi

List of Suppliers

Product Main Page

01

Brand Name : Viberzi

Discovery on Target

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Eluxadoline

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2017 Revenue in Millions : 157

2016 Revenue in Millions : 93

Growth (%) : 68

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Viberzi

Discovery on Target

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Eluxadoline

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2018 Revenue in Millions : 178

2017 Revenue in Millions : 157

Growth (%) : 13%

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Viberzi

Discovery on Target

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Eluxadoline

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2019 Revenue in Millions : 190

2018 Revenue in Millions : 178

Growth (%) : 7

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Viberzi

Discovery on Target

Not Confirmed

Contact Supplier

Contact Supplier

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Eluxadoline

Main Therapeutic Indication : Gastrointestinal Disorders

Currency : USD

2016 Revenue in Millions : 93

2015 Revenue in Millions : 12

Growth (%) : 675

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info